John P. Iwanicki discusses cancer drug patent dispute in Chemical & Engineering News

May 21, 2014

John P. Iwanicki weighs in on the recent dispute over the patent application for TIC10, an anticancer agent set to enter human clinical trials, in “Tug of War Over Promising Cancer Drug Candidate,” in Chemical & Engineering News.

Please click here to read the article.

Posted: May 21, 2014

Contact Banner Witcoff Share on LinkedIn View this page as a pdf Share on Twitter Email this page Print this page